Kiniksa Pharmaceuticals, Ltd Earning Date (KNSA)

USA |NASDAQ |USD

KNSA Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Feb 21, 2022 Dec 2021 $-0.39 $-0.44 $-0.79
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Feb 21, 2022 Dec 2021 $16.15M $12.10M $0.00

Kiniksa Pharmaceuticals, Ltd's next earnings date is Monday, Feb 21, 2022 for the fiscal quarter ending Dec 2021.

KNSA Earnings Date & History Chart

KNSA Earnings & Revenue Forecast

KNSA Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $-0.39 $-0.49 $-0.28
Mar 2022 3 $-0.57 $-0.63 $-0.47
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $-2.17 $-2.27 $-2.05
Dec 2022 3 $-1.89 $-2.27 $-1.56

KNSA Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 4 / 0 $-0.66 $-0.66 $-0.73
Mar 2022 2 / 0 $-0.63 $-0.63 $-0.67
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 4 / 0 $-2.63 $-2.63 $-2.97
Dec 2022 3 / 0 $-2.19 $-2.19 $-2.35

KNSA Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 4 $16.15M $13.00M $19.13M
Mar 2022 2 $18.71M $13.13M $24.30M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $36.75M $35.93M $38.93M
Dec 2022 4 $119.43M $78.64M $144.15M

KNSA Earnings Date & Revenue History

KNSA Earnings History

|
Show More
Show More

KNSA Revenue History

|
Show More
Show More

Kiniksa Pharmaceuticals, Ltd Next Earnings Date & Report

KNSA Next Earnings Date & Report Preview: Dec 2021 (FQ)

KNSA's next earnings date is Monday, Feb 21, 2022 for the fiscal quarter ending Dec 31, 2021.

According to 4 analysts, the average EPS estimation for Kiniksa Pharmaceuticals, Ltd's next quarterly earnings is $-0.39, with a low EPS estimation of $-0.49, and a high estimation of $-0.28.

Over the last 1 month, EPS estimates have seen 4 upward revisions and 0 downward. The EPS 1 month trend is $-0.66, the last 2 month trend is $-0.66, and the 3 month trend is $-0.73.

Based on 4 analysts, the average revenue estimation is $16.15M, with a low revenue estimation of $13.00M, and a high estimation of $19.13M.

Kiniksa Pharmaceuticals, Ltd Previous Earnings Dates & Reports

KNSA Previous Earnings Date & Report Recap: Sep 2021 (FQ)

Kiniksa Pharmaceuticals, Ltd's previous earnings date was Nov 1, 2021 for its fiscal quarter ended Sep 30, 2021.

KNSA's earnings per share (EPS) was $-0.44, beating the consensus analysts forecast of $-0.65 by 32.31%.

The EPS was higher than the previous fiscal quarter (Jun 2021) by -27.87%, and higher than the same period a year before (Sep 2020) by -33.33%.

Revenues were $12.10M.

The company reported a net income of $-30.54M.

Free cash flow for the quarter was $-68.74M , compared to $-38.84M last quarter and $-34.33M a year before.

KNSA ended the quarter with $13.49M in total debt, an increase of 119.85% compared to the previous quarter, and an increase of 772.01% compared to the same quarter a year before.

KNSA Previous Earnings Date & Report Recap: Dec 2020 (FY)

Kiniksa Pharmaceuticals, Ltd's previous annual earnings date was Feb 23, 2021 for its fiscal year ended Dec 31, 2020.

KNSA's earnings per share (EPS) was $-2.58, missing the consensus analysts forecast of $-2.43 by 6.17% , and lower than the previous year's EPS (Dec 2019) by 4.00%.

Revenues were $0.00.

The company reported a net income of $-161.38M.

Kiniksa Pharmaceuticals, Ltd reported a free cash flow of $-136.81M for its fiscal year, compared to $-161.57M a year ago.

The company ended the fiscal year with $6.99M in total debt. lala